Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer

被引：1
|
作者：
Havard, Robert [1 ]
Henry, N. Lynn [1 ]
机构：
[1] Univ Utah, Dept Internal Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 28期
关键词：
21 gene recurrence score; 70 gene signature; breast cancer; chemotherapy; multiparameter genomic assays; prediction; prognosis; ADJUVANT SYSTEMIC THERAPY; AMERICAN SOCIETY; GENE-EXPRESSION; GUIDE DECISIONS; WOMEN; VALIDATION; SIGNATURE; BIOMARKERS; ASSAY;
D O I：
10.2217/fon-2017-0452
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：2507 / 2510
页数：4
相关论文
共 50 条
  • [1] Decision-making in early breast cancer: guidelines and decision tools
    Baum, M
    Ravdin, PM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (06) : 745 - 749
  • [2] Decision-making surrounding adjuvant chemotherapy in young women with early stage breast cancer
    Rosenberg, Shoshana M.
    Sepucha, Karen
    Ruddy, Kathryn J.
    Schapira, Lidia
    Come, Steven
    Borges, Virginia
    Morgan, Evan
    Lin, Nancy U.
    Gelber, Shari
    Tamimi, Rulla M.
    Partridge, Ann H.
    CANCER RESEARCH, 2015, 75
  • [3] Exploring and supporting older women's chemotherapy decision-making in early-stage breast cancer
    Karuturi, Meghan S.
    Giordano, Sharon H.
    Hoover, Diana S.
    Volk, Robert J.
    Housten, Ashley J.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (02) : 170 - 175
  • [4] Exploring and supporting older women's chemotherapy decision-making in early-stage breast cancer.
    Karuturi, Meghan Sri
    Housten, Ashley
    Giordano, Sharon H.
    Hoover, Diana
    Volk, Robert Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [5] Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients
    Patricia Marino
    Carole Siani
    François Bertucci
    Henri Roche
    Anne-Laure Martin
    Patrice Viens
    Valérie Seror
    Breast Cancer Research and Treatment, 2011, 129 : 401 - 409
  • [6] Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients
    Marino, Patricia
    Siani, Carole
    Bertucci, Francois
    Roche, Henri
    Martin, Anne-Laure
    Viens, Patrice
    Seror, Valerie
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (02) : 401 - 409
  • [7] Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review
    Al-Allak, Asmaa
    Lewis, Paul D.
    Bertelli, Gianfilippo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (08) : 1033 - 1043
  • [8] Integrating Decision-Making Support in Geocollaboration Tools
    Antunes, Pedro
    Zurita, Gustavo
    Baloian, Nelson
    Sapateiro, Claudio
    GROUP DECISION AND NEGOTIATION, 2014, 23 (02) : 211 - 233
  • [9] Integrating Decision-Making Support in Geocollaboration Tools
    Pedro Antunes
    Gustavo Zurita
    Nelson Baloian
    Claudio Sapateiro
    Group Decision and Negotiation, 2014, 23 : 211 - 233
  • [10] Online accounts of gene expression profiling in early-stage breast cancer: Interpreting genomic testing for chemotherapy decision making
    Ross, Emily
    Swallow, Julia
    Kerr, Anne
    Cunningham-Burley, Sarah
    HEALTH EXPECTATIONS, 2019, 22 (01) : 74 - 82
12345